Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0980
+0.0010 (1.03%)
Apr 28, 2026, 3:11 PM HKT

Tianda Pharmaceuticals Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2022 2021 - 2017
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22 2021 - 2017
Market Capitalization
211277363469871501
Upgrade
Market Cap Growth
-41.67%-23.67%-22.48%-46.17%73.82%15.35%
Upgrade
Enterprise Value
278314358380787493
Upgrade
Last Close Price
0.100.130.170.210.390.21
Upgrade
Forward PE
-6.556.556.556.556.55
Upgrade
PS Ratio
0.650.861.100.881.590.98
Upgrade
PB Ratio
0.460.610.720.791.330.64
Upgrade
P/TBV Ratio
0.680.900.940.951.640.79
Upgrade
P/FCF Ratio
----12.69-
Upgrade
P/OCF Ratio
----8.55-
Upgrade
EV/Sales Ratio
0.860.971.090.711.440.97
Upgrade
EV/FCF Ratio
----11.47-
Upgrade
Debt / Equity Ratio
0.290.290.250.190.220.20
Upgrade
Debt / EBITDA Ratio
---20.85--
Upgrade
Debt / FCF Ratio
----2.06-
Upgrade
Net Debt / Equity Ratio
0.150.150.07-0.10-0.34-0.24
Upgrade
Net Debt / EBITDA Ratio
-2.78-2.78-1.4660.108.046.46
Upgrade
Net Debt / FCF Ratio
---1.170.58-3.273.09
Upgrade
Asset Turnover
0.430.430.390.53-0.44
Upgrade
Inventory Turnover
4.474.473.384.88-3.86
Upgrade
Quick Ratio
0.590.590.690.891.401.83
Upgrade
Current Ratio
0.830.830.861.101.542.13
Upgrade
Return on Equity (ROE)
-14.61%-14.61%-11.19%-4.01%--2.74%
Upgrade
Return on Assets (ROA)
-4.47%-4.47%-4.02%-1.81%--2.40%
Upgrade
Return on Invested Capital (ROIC)
-10.32%-10.15%-10.06%-6.02%-13.65%-6.81%
Upgrade
Return on Capital Employed (ROCE)
-10.60%-10.60%-10.50%-4.80%-9.70%-4.90%
Upgrade
Earnings Yield
-33.22%-25.24%-16.89%-5.15%-6.27%-3.95%
Upgrade
FCF Yield
---8.34%-21.13%7.88%-12.37%
Upgrade
Dividend Yield
---1.22%0.89%1.21%
Upgrade
Total Shareholder Return
---1.22%0.89%1.21%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.